tbuckley/cabot-search huggingface dataset:
RAPID ABSORPTION OF MERCURIC CHLORID IN A CASE OF POISONING
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Pions, ions, neutrons, protons "expanding scope of radiotherapy'
Journal: JAMA (1981)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Role of Phermones and Kairmones for Insect Suppression Systems and Their Possible Health and Environmental Impacts
Authors: E. F. Knipling
Journal: Environmental Health Perspectives (1976)

Insects produce pheromones as a chemical communication system to facilitate reproduction. These highly active chemical attractants have been synthesized for some of the most important insect pests, including the boll weevil, gypsy moth, codling moth, tobacco budworm, European corn borer, and several bark beetles. While none of the synthetic sex attractants have yet been developed for use in insect control, they offer opportunities for the future both as control agents and to greatly improved insect detection. Investigations are underway on insect trapping systems employing the phermones and on air permeation techniques to disrupt insect reproduction. The pheromones are generally highly species-specific and are not likely to pose hazards to nontarget organisms in the environment. Toxicological studies indicate that they are low in toxicity to mammals, birds, and fish, but adequate toxicological data are necessary before they can be registered for use in insect control. Another new class of compounds called kaironomes has been discovered. These chemicals are involved in the detection of hosts or prey by insect parasites and predators. Kairomones may prove useful in manipulating natural or released biological agents for more effective biological control of insect pests. No information is yet available on the toxicology of these chemicals.
Mother Tongue
Authors: Charu Agrawal, Daniel Epner
Journal: JAMA Oncology (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Authors: J. Beck-Ripp, M. Griese, S. Arenz, C. Köring, B. Pasqualoni, P. Bufler
Journal: European Respiratory Journal (1999)

Salmeterol xinafoate is an inhaled long-acting beta2-adrenoceptor agonist recently introduced for the treatment of asthma. Both in vitro and animal studies suggest that it may have anti-inflammatory activities of benefit in this disease. To assess this directly, the effects of 6 weeks9 treatment with salmeterol on indices of clinical activity, airway dysfunction and inflammation in subjects with stable atopic asthma were investigated. In a double blind study, asthmatic patients were randomized to 6 weeks9 treatment with either salmeterol 50 microg twice daily (n=14) or placebo (n=12). They underwent bronchoscopy with bronchoalveolar lavage (BAL) and bronchial biopsy immediately before starting treatment and again after 6 weeks. Treatment with salmeterol improved clinical indices of asthma activity, but there were no changes in BAL differential cell counts or mediator levels, and no change in T-cell numbers or activation status. In the biopsy specimens there were no changes in numbers of inflammatory cells, sub-basement membrane collagen deposition or mast cell degranulation. Regular treatment with salmeterol improves clinical indices of asthma but has no effect on the underlying inflammatory process. These findings strengthen guideline recommendations that long-acting beta2-agonists should not be prescribed as sole antiasthma medication.
Manuscripts Approved for JNCI, March 15 to April 15, 1960
Journal: JNCI Journal of the National Cancer Institute (1960)

Journal Article Manuscripts Approved for JNCI, March 15 to April 15, 1960 Get access JNCI: Journal of the National Cancer Institute, Volume 24, Issue 5, May 1960, Page 1241, https://doi.org/10.1093/jnci/24.5.1241 Published: 01 May 1960
ASSOCIATION NEWS.
Journal: JAMA (1898)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Respiratory Viruses
Authors: A M Lerner
Journal: Annals of Internal Medicine (1969)

Editorial Notes1 October 1969Respiratory VirusesA. MARTIN LERNER, M.D.A. MARTIN LERNER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-71-4-860 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptRecent developments in our knowledge of the respiratory viruses and in means of prophylaxis against them were reviewed by a World Health Organization (WHO) scientific group that met in Geneva from October 9 through October 14, 1967. This review is now summarized in a readable, brief bulletin of 100 pages in the WHO Technical Report Series*. Major viruses of the group under consideration are influenza viruses, parainfluenza viruses, adenoviruses, and rhinoviruses. Occasionally enteroviruses are respiratory pathogens. The report was written before the recent pandemic due to influenza A2 (Hong Kong).PRESENT STATUSCommercial preparations of influenza virus vaccine aim at... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Wayne State University School of Medicine Detroit, Mich.*Respiratory Viruses. Report of a WHO Scientific Group. World Health Organization Technical Report Series no. 408. 100 pages. World Health Organization, Geneva, 1969. Price, $1.75. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 October 1969Volume 71, Issue 4Page: 860-861KeywordsGlobal healthInfluenza virusesProphylaxisRespiratory pathogensRhinovirus infectionVaccines ePublished: 1 December 2008 Issue Published: 1 October 1969 PDF downloadLoading ...
Essential reduction of radiation exposure to operator and staff during cardiac interventions by analysis of radiation leakages and improved lead shielding Eberhard Kuon, Moritz Schmitt, Johannes B. Dahm. Department of Internal Medicine, Clinic Franconian Switzerland, Ebermannstadt, Germany, Department of Internal Medicine, Ernst-Moritz-Arndt-University, Greifswald, Germany
Journal: Journal of the American College of Cardiology (2001)
Horse
Authors: M. Therese Southgate
Journal: JAMA (2001)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
25 years in continuing medical education. The silver anniversary of the AMA PRA
Authors: A. M. Osteen
Journal: JAMA (1993)

THE AMERICAN Medical Association Physician's Recognition Award (AMA PRA) was established by the AMA House of Delegates in December 1968. As the time approaches to celebrate the PRA's 25th anniversary, we take stock of the award, how it has changed, and how it has not. It is also an opportunity to look briefly at other ways in which the AMA has been involved in continuing medical education (CME). These other involvements have perhaps been more important to CME than the PRA award itself. The resolution establishing the award set out the following rationale and goals: To provide recognition for the many thousands of physicians who regularly participate in CME. To encourage all physicians to keep up-to-date and to improve their knowledge and judgment by CME. To provide reassurance to the public that America's physicians are maintaining their competence by regular participation in CME. To emphasize the AMA's position as a
Monitoring for mendacity
Authors: S. Vaisrub
Journal: JAMA (1979)

It may be more than a coincidence that Sir Arthur Conan Doyle, the creator of Sherlock Holmes, was a physician. The observant eye and deductive logic of the detective prototype are also hallmarks of the astute physician who seeks clues to diagnosis or who traces the source of an epidemic. Kinship between the two callings becomes even closer when a pathologist aids in solving a crime or a clinician uses his skill to detect deception on the part of a patient. Deception by patients takes many forms. It may be deliberate in malingering, subconsciously motivated in hysteria, shamefully concealed in child abuse, and self-destructive in the Munchausen syndrome. More commonly, deception manifests itself as noncompliance with physicians' orders. Physicians are well aware of noncompliance. They suspect it whenever a patient does not respond as expected to prescribed therapy, be it exercise, medication, or a restricted diet. Justly or unjustly, they
Thyroxine "Addicts"
Authors: R. F. Harvey
Journal: BMJ (1973)

Four patients are described who were surreptitiously taking thyroxine-containing tablets. In two cases this caused considerable diagnostic problems. The diagnosis should be considered in patients with clinical features of hyperthyroidism (but without goitres or proptosis), who appear psychiatrically abnormal and whose thyroid function tests show conflicting results.
Abstract 1106: <i>In Vivo</i> Molecular Imaging for Cardiac Regeneration
Authors: Jingxiong Wang, Brian Rabinovich, Sui Zhang, Elizabeth Shpall, Juri G Gelovani, James T Willerson, Edward T Yeh
Journal: Circulation (2007)

Introduction We have showed that the transplanted human peripheral blood CD34 + cells can transform into smooth muscle, endothelial, and myocardial cells in infarcted hearts in mice. However, the fate of the transplanted cells in vivo is unknown. Hypothesis Molecular imaging is of substantial value for non-invasively tracking the fate of transplanted stem cells and for developing stem cell transplantation toward a clinically accepted therapy. Objectives To develop and validate molecular imaging techniques for reliably tracking the fate of transplanted stem cells in ischemic hearts in vivo and to follow the tempo-spatial dynamics of their transformation and function. Methods Using SCID mice transplanted with the CD34 + cells after myocardial infarction as a model, the CD34 + cells were transduced with 6 lentivectors bearing a fusion reporter gene driven by 6 different promoters. The reporter protein consists of herpes simplex virus thymidine kinase, green fluorescence protein, and luciferase, allowing us to monitor in vivo the fate of transplanted cells with bioluminescence imaging (BLI) and positron emission tomography (PET). In order to assess cardiac function, the mice were scanned with a 7.0-T MRI. Results The virus containing human ubiquitin promoter produced stable transduction efficiency 30%. Thereafter, 10 6 transduced CD34 + cells were injected into peri-infarct area per mouse heart. At day 7, the BLI signals in hearts were 1.4 ± 0.12x10 5 photons(p)/s/cm 2 /sr (n=6). At day 14, the PET signals were 0.05 ± 0.001 injection dose (ID) %/g. Both signals increased progressively to week 4, then remained in plateaus of 1.8 ± 0.15x10 5 p/s/cm 2 /sr and 1.38 ± 0.002 ID%/g, respectively until week 6, thereafter declining gradually, but were still as high as 9 ± 0.11x10 4 p/s/cm 2 /sr and 0.92 ± 0.001 ID%/g at week 16, indicating the transplanted CD34 + cells survive and function in the host. Co-register MRI/PET showed the concordance of anatomic and functional consequences after the transplantation of the CD34 + cells. Conclusion Our results demonstrate the feasibility of using molecular imaging to reliably track human CD34 + cell transplanted into infarcted hearts in mice, thus identifying PET/MRI imaging as a means to trace stem cell transplants in injured hearts.
Drug antisubstitution laws: reprise
Journal: JAMA (1972)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Oral Contraceptives
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Chronic Infection and the Risk for Heart Disease
Journal: Annals of Internal Medicine (1999)

Summaries for Patients19 October 1999Chronic Infection and the Risk for Heart DiseaseSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-131-8-199910190-00039 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Some studies suggest that people with chronic infection are more likely to have common types of cardiovascular disease (coronary heart disease and strokes) than people without chronic infection. However, these studies have not been able to sort out whether chronic infection occurred before or after the disease developed. Some of the bacteria and viruses (“germs”) that researchers have found in people with coronary disease include Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus.Why did the researchers do this particular study?The researchers wanted to find out ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Baseline IgG Antibody Titers to Chlamydia pneumoniae, Helicobacter pylori, Herpes Simplex Virus, and Cytomegalovirus and the Risk for Cardiovascular Disease in Women.” It is in the 19 October 1999 issue of Annals of Internal Medicine (volume 131, pages 573-577). The authors are P.M. Ridker, C.H. Hennekens, J.E. Buring, R. Kundsin, and J. Shih.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoBaseline IgG Antibody Titers to Chlamydia pneumoniae, Helicobacter pylori, Herpes Simplex Virus, and Cytomegalovirus and the Risk for Cardiovascular Disease in Women Paul M. Ridker , Charles H. Hennekens , Julie E. Buring , Ruth Kundsin , and Jessie Shih Metrics 19 October 1999Volume 131, Issue 8Page: 573KeywordsBacteriaBloodCOVID-19Cardiovascular diseasesHealth surveysHerpes simplexInfectious diseasesLongitudinal studiesMyocardial infarctionStroke ePublished: 15 August 2000 Issue Published: 19 October 1999 Copyright & PermissionsCopyright © 1999 by American College of Physicians. All Rights Reserved.Loading ...
Table of Contents
Authors: Jeremy Leventhal, Christina Wyatt, Michael Ross, Bernd Hohenstein, Anja Verhulst, Pieter Evenepoel, Patrick D'haese, Hannah Burton, Anthony Dorling, Ben Caplin, Dorothea Nitsch, Anne Blanchard, Detlef Bockenhauer, Davide Bolignano, Lorenzo Calò, Etienne Cosyns, Olivier Devuyst, David Ellison, Fiona Karet Frankl, V Knoers, Martin Konrad, Shih-Hua Lin, Rosa Vargas-Poussou
Journal: Kidney International (2016)
HOSPITALS FOR THE INSANE—THEIR SCOPE AND DESIGN.
Authors: EDWARD F. WELLS
Journal: JAMA (1895)

Shall the State have the custody of all its insane, or shall certain classes be relegated to county care? Shall the State care for the acute and the chronic insane separately or shall the hospital and the asylum be combined in one institution? Shall employment, especially agricultural, be afforded the patients, and if so to what extent? Should epileptics be received into insane hospitals or should they be cared for in a separate institution? Should any class of the insane be "boarded out," as practiced at Gheel, in Scotland and in Massachusetts? What should be the scope and design of the modern institution for the insane? These are questions of perennial and engrossing interest to the social economist, the legislator, the executives of our States and to the public at large, and they will be considered, with especial reference to the present status in Illinois, as fully as the limits